JCJugun Prakash Chinta

Jugun Prakash Chinta

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Jugun Prakash Chinta has a total of 49 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Investigation on the Cytotoxicity of Hydroxycinnamic and Hydroxybenzoic Acid-Based Natural Antioxidant Conjugated Terpyridine Analogues toward Triple-Negative Breast Cancer

    by Anindya Roy, Nitisha Beniwal, Aritri Shome, Aravind Kumar Rengan, Jugun Prakash Chinta

    Higher intracellular ROS concentration of TNBC cells may serve as a therapeutic target to develop antioxidant-based drugs to treat such cancers. The HCA-conjugated terpyridine-copper analogues are reported for the selective treatment of TNBC, but the investigation on the antiproliferative activities remains to be elucidated. Herein, a set of terpyridine-conjugated HBA and HCA derivatives and their ROS-induced products were isolated and evaluated for their anti-TNBC properties. In vitro studies on 4T1 cell lines revealed that the ROS-oxidized intermediates showed potential therapeutic activity to cause the antiproliferative activity of their parent analogues. Further, the presence of copper was also found to enhance the anticancer activity of these derivatives with high selectivity toward TNBC. Due to the presence of natural antioxidant residues, all these derivatives were found to be biocompatible, as studied over NIH/3T3 cell lines. These results illustrate the involvement of ROS-generated cytotoxic intermediates, responsible for the therapeutic applicability of natural antioxidant-based derivatives toward TNBC.

  • Copper-assisted anticancer activity of hydroxycinnamic acid terpyridine conjugates on triple-negative breast cancer

    by Anindya Roy, Sajmina Khatun, Prashant Dattatraya Dewale, Aravind Kumar Rengan, Jugun Prakash Chinta

    The development of active therapeutic agents to treat highly metastatic cancer while minimizing damage to healthy cells is of utmost importance. Due to potential antioxidant properties, hydroxycinnamic acid derivatives (caffeic acid and p-coumaric acids) were found to inhibit highly metastatic breast cancer cell growth both in vitro and in vivo without much effect on normal cells. Especially due to the structure–activity relationships, ester and amide derivatives of hydroxycinnamic acids are reported to gain much higher radical scavenging ability than their naked hydroxycinnamic acid analogs like caffeic acid and p-coumaric acid. These results prompted us to design a set of ligands by incorporating an amide moiety on caffeic acid and p-coumaric acid to achieve the least toxicity towards healthy cell lines. Further, the Cu(II) complexes of amide-coupled caffeic acid and p-coumaric acid ligands have been explored for their therapeutic activity on triple-negative breast cancer and other cancer cells like colon, and prostate cancer. The Cu(II) complexes (4 & 5) were characterized by UV-Vis spectroscopy, FTIR, and X-band EPR spectroscopy. The trigonal bipyramidal geometry of complexes was confirmed by the X-band EPR spectra recorded in solution state at liquid N2 temperature. The purity of the complexes was determined by elemental analysis and HPLC traces. Initially, Calf thymus DNA (ct-DNA) binding studies with the complexes were explored. The results suggested the complexes (4 & 5) bind majorly through an intercalative mode of binding with ct-DNA, whereas no significant binding was observed for the bare organic ligands (2 & 3). The intercalation binding modes of 4 and 5 were further supported by UV-visible spectroscopy, ct-DNA melting point analysis, and CD spectroscopy. Moreover, these complexes showed better activity towards cisplatin-resistant TNBC cell lines (4T1, a TNBC cell line derived from the mammary gland tissue of a mouse). The combination of antioxidants and Cu(II) as the metal center made the complexes more cytotoxic toward cancer cell lines (4T1) (IC50 ∼ 3.5 ± 2.5 μM) and the least toxic toward healthy cells (L929) (IC50 ∼ 15 ± 5 μM). Finally, the mechanism of cell death was studied using JC-1 staining and a cell colony formation assay. These studies might help in designing safer anticancer drugs for treating more aggressive types of cancer.


  • Development of a magnetic solid phase extraction method for gemcitabine from rat plasma by using magnetic graphene oxide calix[6]arene composite and its application to pharmacokinetics

    by Babji Palakeeti, Namburi L A Amara Babu, Jugun Prakash Chinta

    A highly accurate and precise HPLC-UV method was developed for identification and quantification of gemcitabine anti-cancer drug in rat plasma. A new magnetic graphene oxide-based calixarene composite was developed and used as a solid phase for extraction of gemcitabine from rat plasma. Extraction efficiency has been studied by varying different experimental variables (eluent type, sorbent amount, extraction time and eluent volume etc.) and these were evaluated and optimized. Magnetic solid phase extraction (MSPE) conditions such as amount of solid phase, extraction solvents and their amounts, and adsorption and desorption times were optimized for getting better recoveries. Under the optimized conditions, linearity was evaluated with good correlation coefficient value R2 (0.9993). Limit of detection (2.0 ng/mL) and limit of quantification (13.0 ng/mL) was assessed using signal-to-noise ratio method. Intraday precision RSD values of gemcitabine (GEM) were found to be less than 4.6% and interday precision values are less than 6.8%. The results obtained during the robustness study were RSD values between 1.2 and 4.6%; these results indicate that the method has effective performance and reliability. The recovery percentages of gemcitabine at three QC level concentrations were obtained in the range from 97.6 to 100.2%.


  • Open Access

    Simple and efficient method for the quantification of antiepileptic drugs in human plasma by using magnetic graphene oxide-β-cyclodextrin composite as a sorbent

    by Babji Palakeeti, K. Vijendar Reddy, K. Vengatajalabathy Gobi, Pothuraju Nageswara Rao, Jugun Prakash Chinta

    Background: In recent days, solid-phase extraction methods are widely utilized for the extraction of drug molecules from plasma samples due to their easy operating procedures and low matrix effect. The trace-level solid-phase extraction of three structurally related antiepileptic drugs brivaracetam (BVC), eslicarbazepine acetate (ESL), and carbamazepine (CBZ) was investigated by using a magnetic porous material graphene oxide-β-cyclodextrin (MGO-CD). Morphology, magnetic properties, and structure of the synthesized MGO-CD were characterized by using FT-IR, SEM, XRD, and VSM. Results: Solid-phase extraction (SPE) methods were used to extract the analytes from human plasma. Different extraction solvents such as acetonitrile (ACN), methanol (MeOH), acetone, chloroform (CHCl3), tertiary butyl diethyl ether (TBDE), and ethyl acetate (EtOAc) with variable polarities were used to extract drug molecules from MGO-CD. The linearity analysis showed good correlation coefficient values (R2) of 0.9989, 0.9995, and 0.9982 for BVC, ESL, and CBZ respectively. The LOD and LOQ ranges were found to be 6.14–28.32 ng mL−1 and 20.45–94.31 ng mL−1 respectively. Conclusion: The high accuracy and precision made the developed HPLC method with MGO-CD a suitable alternative for the bioequivalence study of BVC, ESL, and CBZ in human plasma. This developed HPLC-UV method has good efficiency for recoveries and good linearity and is simple to handle. And also, it gave low retention time for the three antiepileptic drugs within 8 min. It provides high efficiency for the extraction of trace-level substances from human plasma.


  • Open Access

    Development of new stability indicating UPLC-UV method for the extraction and quantification of perindopril and indapamide from human plasma

    by Babji Palakeeti, Pothuraju Nageswara Rao, Jugun Prakash Chinta

    Background: The hypertension and cardiovascular ailments are the leading cause of deaths worldwide. The combination therapy was found to be effective on the cardiovascular illness by reducing the blood pressure. The indapamide and perindopril combination therapy showed excellent results on reducing high blood pressure. With this in mind, the stability indicating reverse phase UPLC method was developed for the simultaneous identification and quantification of indapamide and perindopril from human plasma. In this work, we developed a new solid phase extraction method for the extraction of indapamide and perindopril in human plasma. It is a simple, accurate, and selective method for the extraction of these two drugs from human plasma with elution time of 2 min. The extracted drugs were identified and quantified by using stability indicating UPLC method. The method showed high recovery rate as well as low detection and quantification limits of two drugs. Results: A novel, simple, highly accurate, and precise stability indicating ultra-performance liquid chromatography (UPLC) method was developed for the identification and quantification of perindopril (PP) (brand name Coversyl) and indapamide (IP) (brand name Lorvas) from human plasma. In this UPLC method, HSS C18 column (100 × 2.1 mm, 1.8 μm) and mobile phase acetonitrile (ACN), 10 mM KH2PO4 buffer solution (pH 3.0) mixture was used in the ratio of 65:35. Colum temperature of 30 °C, flow rate of 1.0 mL per minute and UV wave length of 254 nm were used. PP and IP were eluted below 2 min runtime with high resolution. Solid phase extraction (SPE) method was used for the extraction of PP and IP from human plasma. Different solvents were used to extract the analyte from SPE such as ACN, methanol, acetone, tertiary butyl diethyl ether (TBDE), chloroform (CHCl3), and ethanol (EtOH). Among these, ACN gave good recovery percentages (94.56 to 101.58%). From the linearity graph, good correlation coefficient values of 0.9996 for PP and 0.9997 for IP were achieved. The coefficient variance values for intra and inter day precision is in between 1.08 and 12.5%. The LOD and LOQ values were determined by the signal to noise ratio method. LOD and LOQ values for IP and PP were found to be 8.6 and 33.5 ng/mL and 28.33 and 110.5 ng/mL respectively. The developed method was statistically validated as per ICH guidelines. Conclusion: In summary, a novel stability indicating UPLC-UV method was developed and validated for the simultaneous identification and quantification of perindopril and indapamide drugs in human plasma and tested the stability as per ICH guidelines. It is a simple, accurate, and specific method for the extraction of these two drugs from human plasma and eluted within 2 min runtime. The method showed high recovery rate as well as low detection and quantification limits of two drugs. The developed method is suitable for routine analysis as well as in bioanalytical and clinical studies. Graphical


  • Carbon Nanotube and Semiconductor Nanorods Hybrids: Preparation, Characterization, and Evaluation of Photocurrent Generation

    by Jugun Prakash Chinta, Nir Waiskopf, Gur Lubin, David Rand, Yael Hanein, Uri Banin, Shlomo Yitzchaik

    Carbon nanotubes (CNTs) and semiconductor nanocrystals (SCNCs) are known to be interesting donor–acceptor partners due to their unique optical and electronic properties. These exciting features have led to the development of novel composites based on these two nanomaterials and to their characterization for use in various applications, such as components in sensors, transistors, solar cells and biomedical devices. Two approaches based on covalent and noncovalent methods have been suggested for coupling the SCNCs to CNTs. Most covalent conjugation methods used so far were found to disrupt the electronic structure of the CNTs or interfere with charge transfer in the CNT–SCNC interface. Moreover, it offers random and poorly organized nanoparticle coatings. Therefore, noncovalent methods are considered to be ideal for better electronic coupling. However, a key common drawback of noncovalent methods is the lack of stability which hampers their applicability. In this article, a method has been developed to couple semiconductor seeded nanorods onto CNTs through π–π interactions. The CNTs and pyrene conjugated SCNC hybrid materials were characterized by both microscopic and spectroscopic techniques. Fluorescence and photocurrent measurements suggest the proposed pi-stacking approach results in a strong electronic coupling between the CNTs and the SCNCs leading to better photocurrent efficiency than that of a covalent conjugation method reported using similar SCNC material. Overall, the CNT–SCNC films reported in the present study open the scope for the fabrication of optoelectronic devices for various applications.